Background: Consumption of oily fish or fish oil during pregnancy, lactation and
with the concurrent rise in omega-6 polyunsaturated fatty acids (n-6 PUFA) and vitamin D deficiency.
1,2 n-3 PUFA have an anti-inflammatory effect by influencing the cell membrane structure, cell signalling and antigen presentation. 3, 4 Diets rich in the n-3 PUFA eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) have been shown to decrease allergic symptoms in food-allergic mice. DHA-rich diet also protected against allergic sensitization, indicating both primary and secondary prevention.
5
Several studies have indicated a favourable allergic outcome in infants related to maternal n-3 PUFA consumption during pregnancy, although there have been inconsistent results between studies. 6 The Childhood Asthma Prevention Study in Australia showed that infants who received fish oil supplementation from birth had increased n-3 PUFA levels in association with a decreased allergenspecific T helper cell 2 (Th2) response and elevated polyclonal Th1 response, indicating that n-3 PUFA have immunomodulatory effects during a critical time of immune vulnerability in early infant life. 7 The improved infant n-3 PUFA status did not prevent childhood allergic disease. 8, 9 Low vitamin D status has been reported in concordance with an increase in allergic diseases in infancy. Vitamin D modulates the action of immune cells, such as T and B cells, monocytes and dendritic cells, and may, therefore, influence the development of allergic diseases, including food allergy. 10, 11 Studies have shown conflicting results regarding the association between vitamin D and the development of food allergy, but recent studies have suggested a rather protective role. 1, 12, 13 To examine whether cod fish oil supplementation, which is rich in n-3 PUFA and vitamins A and D, has an effect on food allergy development, we evaluated the Icelandic birth cohort taking part in the EuroPrevall birth cohort study on food allergies using a questionnaire database as well as information on sensitization and confirmed food allergy. Results published so far from the EuroPrevall birth cohort show that, compared with the other participating European countries, Iceland is relatively high in food allergy prevalence.
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2 | ME TH ODS
| Study design and setting
This study is a longitudinal observational study without intervention.
The Icelandic directorate of health recommends that infants be given vitamin D, 10 lg daily, from age 2 weeks until 6 months when it is recommended to begin supplementing daily 5 mL dose of fish oil.
However, many parents in our cohort were not compliant with these recommendations, which provided an opportunity to investigate the relationship between vitamin D and fish oil supplementation and food allergy in Icelandic infants.
The analysis was performed using data collected from the EuroPrevall birth cohort study in Iceland conducted within the collaborative research initiative EuroPrevall. The methodology of the birth cohort has previously been described in detail. 17 Participation was offered to parents of children born in Iceland from 2005 to mid-2008. Participating children were followed from birth to 2.5 years of age. Data for 1341 children were collected after birth and included birth data, family history of allergies in parents and siblings, sociodemographic status and environmental exposures.
Parents were asked to call to report any symptoms in their children that were suggestive of food allergy. They underwent a standardized interview by a study nurse and, if needed, by a paediatric allergist, and a decision was made regarding whether to bring the child to the Landspitali University Hospital (LUH) in Reykjavik for interviewing and examination. In addition, parents answered questionnaires over the phone at approximately 12 and 24 months. Data were collected on breastfeeding, complementary intake and food intake of the child and symptoms of allergies. When allergy was suspected, a decision was again made on whether to bring the child to the hospital.
The children who were brought to LUH underwent a physical examination, skin prick testing (SPT) and a blood draw for food-specific immunoglobulin E (IgE) measurements, and when allergy was suspected, a double-blind, placebo-controlled food challenge (DBPCFC) was offered. The DBPCFC diagnosis was based on immediate symptoms or delayed symptoms reported by parents within 24 hours (Appendix S1).
| Data and subjects for this study
The participants in this study were the children who completed a 12-month questionnaire. The primary data used were the questionnaire responses regarding complementary feeding of fish oil and vitamin D during infancy, family history of allergy and demographic factors as well as the results of the hospital allergy examination. In this study, the term regular for both fish oil and vitamin D intake was used to represent administration at least four times per week. Fish oil supplementation is common in Iceland, and it is officially recommended that children should be given fish oil from 6 months of age. The fish oil is primarily from cod and is rich in n-3 PUFA and vitamins A and D (Table S1 ). Vitamin D supplementation is recommended from age 2 weeks. 18 To allow testing for confounding by family allergy history, a family allergy index was computed, measuring the frequency and severity of allergic diseases in first-degree relatives (Appendix S2). In addition,
to allow for quantitative analysis, a sensitization and allergy severity index for the children was computed by combining the results of the IgE measurements, SPT and DBPCFC (Appendix S3). 
| Statistics

| Ethics
The study was approved by The National Bioethics Committee in 
| RESULTS
Of the 1341 children for whom birth data were collected, the 12-month questionnaire was completed for 1304 children, resulting in the participation of 636 girls and 668 boys in this study. The 24-month questionnaire was completed for 1244 children. A total of 515 parents called and were interviewed by a study nurse and, subsequently, by a study physician, that is paediatric allergist, if food allergy was suspected. A total of 249 children were seen at LUH for further investigation.
| Primary findings
The primary result of the study was that regular fish oil use significantly reduced the incidence of food sensitization (RR = 0.51, 95%
CI: 0.32-0.82, P = .006) in Icelandic infants irrespective of their family history of allergy and other investigated confounding factors. Incidence of sensitization and confirmed food allergy were significantly lower in children who began early on regular fish oil (P = .045 and .018, respectively, Table 1 ).
| Demographic factors, fish oil use and vitamin D
Almost half of the study group was given fish oil regularly from the age of 6 months or younger, and a further third began regular fish oil intake at 7-15 months old. Table 2 .045 .018
The table shows the cumulative incidence of sensitization among the children who were not sensitized at 9.5 mo according to whether they began regular fish oil when 3-6 mo old, when 7-9 mo old or whether they did not receive regular fish oil supplementation before 15 mo. The last column shows the incidence of confirmed food allergy among the same children. The last two lines show mean AE standard deviation.
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| 1307 attention in the modelling described below, and none of them were found to have a confounding effect on the primary results.
Children with a family history of allergy did not receive significantly more or less fish oil than other children. Of the 635 children with a family allergy index above the median, 297 (47%) began regular fish oil supplementation at 1-6 months old, and an additional 204 (32%) began supplementation at 7-15 months old. Of the other 639 children who had a low family allergy index, 304 (48%) began regular fish oil intake at 1-6 month old and another 244 (38%) began at 7-15 months old. The family allergy index was also incorporated in the modelling phase and did not alter the results.
| Diagnosed food sensitization and allergy
As stated above, 249 children were seen at LUH after food allergy was suspected. Of these children, 85 (6.5% of the 1304) were diagnosed as sensitized to food based on positive SPT and/or IgE outcomes. For 43 (3.3%) of the 85 children, the diagnosis was confirmed as food allergy with DBPCFC. In 6, 1 and 2 cases, the children were allergic to 2 foods, 3 foods and 4 foods, respectively.
The most common food allergens were hen's eggs and cow's milk, followed by fish and peanuts (Table 3) .
| Fish oil and food allergy-preliminary calculation
There were 595 children, not allergic at 6 months, who received regular fish oil from that age or earlier. Of these, 24 (4.0%) were subsequently diagnosed with food sensitization and 11 (2.0%) with confirmed food allergy. This contrasts with the 241 children who never received regular fish oil. Of these, 27 (11.2%) were diagnosed with food sensitization and 20 (7.9%) with food allergy after age 6 months (P < .001 for both sensitization and confirmed allergy).
Similar computation for vitamin D only, and for vitamin D and fish oil combined, showed marginal but nonsignificant protection of vitamin D (Table S2 ).
| Modelling the relationship between fish oil use and food allergy
The calculation in the previous subsection did not consider the 464 children who began regular fish oil intake after 6 months of age, but they were included in the more detailed analysis illustrated in Figure 1 , which also provides a breakdown by age at F I G U R E 1 Monthly incidence of food sensitization and allergy according to age and fish oil use. The upper part of each bar (lighter colour) shows the incidence of sensitization, diagnosed during the indicated age span, that is not accompanied by a positive double-blind placebocontrolled food challenge (DBPCFC) outcome, and the lower part (darker colour) shows the incidence of sensitization followed by a positive DBPCFC outcome. The numbers above the bars indicate the size of each reference group. On average, regular fish oil intake lowered the incidence of sensitization by a factor of 2.0 (P = .006) and DBPCFC-confirmed allergy by a factor of 1.7 (nonsignificant, P = .095). See Figure S1 for details diagnosis. The analysis is explained in more detail in Figure S1 ; however, briefly, the incidence of sensitization (allergy) among those who had begun regular fish oil intake was compared with the incidence among those who had not. For the analysis, the exact timing of the shift, that is from not getting fish oil to getting regular fish oil, was considered to be 2 weeks after the fish oil start time reported by the parents in the questionnaire(s).
Until age 15 months, the incidence of diagnosed sensitization against food allergens among children who had received regular fish oil was less than half that among the children who had not received regular fish oil, and the same was true for confirmed allergy. After 15 months, the difference in incidence was smaller;
however, firm conclusions cannot be drawn because there were only a few cases.
A proportional hazards model was constructed to estimate the protective effect of fish oil in terms of RR. The detailed results are shown in Table S3 (sensitization) and Table S4 (DBPCFC-allergy). As stated at the beginning of this section, the primary result of the modelling was that regular fish oil use significantly reduced the incidence of food sensitization irrespective of family history of allergy, and also irrespective of sex, mother's age, number of (young) siblings, presence of pets or other animals in the home, smoking in the home, parents' education, mother's use of fish oil during pregnancy and consumption of complementary cow milk in the first week (Table S3, models 15-22, Table S4, Table S1 ). The mothers in the Australian study had F I G U R E 2 Sensitization and allergy severity index according to the frequency of fish oil administration. There was a significant relationship (linear regression t test, P = .013) restricted fish intake in the last trimester, whereas fish intake was not restricted in our study. The additional ingredients in the fish oil may possibly play a role, such as vitamin A, which has been shown to participate in oral tolerance development, 19 and MUFA, but blood MUFA have recently been associated with reduced allergy risk at 2-9 years of age. 20 Fish oil supplementation during pregnancy and lactation is known to have an immunomodulatory and allergy-preventive effect on the offspring. 21 In our study, the effect of postnatal fish oil supplementation on sensitization or confirmed food allergy did not change when accounting for the mother's intake of fish oil during pregnancy. Furthermore, the maternal fish oil consumption during pregnancy in our study did not explain the dose-dependent effect of fish oil intake by the infants on allergy severity.
Another Australian intervention study used, in a double-blind manner, 500-mg tuna fish oil capsules containing 184 mg of omega-3 fatty acids once daily from the age of 6 months vs capsules with sunflower oil. They did not find a significant difference in allergic diseases between the intervention group and the controls up to the age of 3 years apart from reduced atopic cough in the intervention group. 7 Again, the total dose of omega-3 fatty acids in this study was much lower than that in our study (184 mg vs 1000 mg), which could explain the different results between these studies. A high dose of omega-3 fatty acids during pregnancy has been shown to be more favourable for reducing the development of allergic diseases in infancy than a lower dose. tive studies may reflect a short exposure, while repeated measurements reflect ongoing vitamin D exposure and protection. 13 The same research group previously demonstrated that low vitamin D at 6 years of age leads to an increased risk of developing allergic sensitization. 24 In addition to the dose-dependent explanation given above for the difference between the two Australian studies 7, 8 and this study, exposure to the Australian sun may also play a role, by providing all the Australian participants with adequate vitamin D.
The timing of fish oil supplementation seems to be important, as we demonstrated more protection when starting fish oil early. Animal and human studies have indicated that n-3 PUFA can change the expression of genes by an epigenetic mechanism and affect the production of inflammatory mediators and the development of allergic diseases. 25, 26 There is accumulating evidence that supplementation with fish oil rich in PUFA and vitamin D has an effect on the immune system and may, thereby, prevent the development of allergic diseases and that the critical time to initiate supplementation is very early in life. Our results apply to Icelandic children, and it would be interesting to carry out a similar analysis based on the EuroPrevall cohort for other European countries, both within countries and between countries. Further studies are needed to determine which of the ingredients in the cod fish oil explain the protective findings of our study.
| CONCLUSION S
Our study showed that fish oil supplementation in children starting before or at 6 months may decrease food sensitization and food allergy in young children by more than half, with potential large public health implications. The study also indicated that regular fish oil may decrease food allergy severity.
ACKNOWLEDG MENTS
We thank all the families who participated in the EuroPrevall birth cohort study, the medical and nursing staff in the Pediatric 
CONF LICTS OF INTEREST
The authors declare that they have no conflicts of interest.
AUTHOR CONTRIBU TI ONS
Michael Clausen performed the data collection, carried out the initial analyses, drafted the initial manuscript and critically reviewed, 
FI NANCIAL DI SCLOSURE
The authors have no financial relationships relevant to this article to disclose.
O R C I D
